#Canada #Toronto #MolecuLight #Dr. Desvigne #JAB Maui

Enhancing Wound Care with MolecuLight's Technology

MolecuLight Inc., a frontrunner in point-of-care fluorescence imaging for wound management, recently announced an exciting presentation to be made by Dr. Michael N. Desvigne at the 47th Annual JAB Maui Burn & Wound Symposium. This leading event will take place from January 25 to 30, 2025, and focuses on innovative advancements in wound healing, burn care, and infection control. With significant contributions from medical professionals, researchers, and healthcare experts attending, Dr. Desvigne's presentation aims to shed light on the clinical and surgical benefits of MolecuLight's fluorescence imaging technology.

Revolutionizing Surgical Reconstruction

During the symposium, Dr. Desvigne, a certified plastic surgeon and wound care specialist, will present his research, articulating his experiences with fluorescence imaging in the management of infections and preparing the wound bed for surgical reconstruction. His findings demonstrate how the sophisticated fluorescence imaging platform from MolecuLight has dramatically improved infection management and enhanced the readiness of wound beds. This has resulted in better surgical results and expedited recovery times for patients dealing with complex wounds, especially those undergoing reconstructive procedures involving skin grafts, flaps, or skin substitutes.

A Collaborative Surgical Team Approach

Dr. Desvigne plays an integral part in a multidisciplinary team at the Abrazo Arrowhead Hospital and Wound Clinic in Glendale, Arizona, which is known for its excellence in plastic surgery and wound treatment combined with hyperbaric medicine. The approach of this team includes collaboration among various healthcare professionals, such as wound care clinicians, hospitalists, infectious disease physicians, and other surgical experts. This teamwork, coupled with the application of MolecuLight's technology, has led to remarkable results in treating wound infections and performing surgical reconstructions.

Real-Time Visualization for Improved Outcomes

Reflecting on the influence of the MolecuLight technology, Dr. Desvigne stated, “The ability to visualize bacterial infection in real-time using MolecuLight's fluorescence imaging technology has changed our clinical practice. It helps us make more informed therapeutic decisions across all surgical cases, ultimately translating into better outcomes and faster recovery for our patients, along with more cost-effective care.”

Dr. Desvigne is enthusiastic about the opportunity to share these impactful results with colleagues during the JAB Maui symposium and aims to continue advancing the field of wound management.

Importance of Innovations in Wound Care

Anil Amlani, CEO of MolecuLight, expressed his pride in Dr. Desvigne's contribution, indicating that the handling of infection management and patient outcomes in surgical scenarios are profoundly improved due to their breakthrough imaging technology. He emphasized that better surgical results contribute to reduced healthcare costs, enhancing not only patient health but also the efficiency of healthcare provisions.

MolecuLight's fluorescence imaging technology is recognized for its real-time detection and visualization of high bacterial loads in wounds, furnishing clinicians with actionable insights that facilitate precise treatment decisions, leading to faster healing processes. The extensive utilization of the MolecuLight platform by Dr. Desvigne underscores the significant impact it has had on improving patient outcomes undergoing complex wound care and surgical procedures.

About MolecuLight Inc.

MolecuLight Inc. is a privately held medical imaging company known for its groundbreaking wound imaging devices like the MolecuLight iX® and DX™, which are the only FDA-approved Class II devices for real-time detection of high bacterial burdens in wounds. Equipped with substantial clinical evidence, including over 100 peer-reviewed publications, MolecuLight continues to set new standards in wound care technology.

For media inquiries, sales, or further information, please contact Hunter Zudans, Marketing Director at MolecuLight Inc.: +1.484.682.7580, or visit www.moleculight.com.